These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17923542)

  • 21. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
    Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
    Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler).
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2012 May; 90(3):287-90. PubMed ID: 20553232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acute morphologic changes that occur at the optic nerve head induced by medical reduction of intraocular pressure.
    Meredith SP; Swift L; Eke T; Broadway DC
    J Glaucoma; 2007 Sep; 16(6):556-61. PubMed ID: 17873718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme replacement therapy in mucopolysaccharidosis I: altered distribution and targeting of alpha-L-iduronidase in immunized rats.
    Turner CT; Hopwood JJ; Brooks DA
    Mol Genet Metab; 2000 Apr; 69(4):277-85. PubMed ID: 10870845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I.
    Giugliani R; Rojas VM; Martins AM; Valadares ER; Clarke JT; Góes JE; Kakkis ED; Worden MA; Sidman M; Cox GF
    Mol Genet Metab; 2009 Jan; 96(1):13-9. PubMed ID: 19038563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients.
    Tylki-Szymanska A; Marucha J; Jurecka A; Syczewska M; Czartoryska B
    J Inherit Metab Dis; 2010 Apr; 33(2):151-7. PubMed ID: 20217237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.
    Martus P; Stroux A; Budde WM; Mardin CY; Korth M; Jonas JB
    Am J Ophthalmol; 2005 Jun; 139(6):999-1009. PubMed ID: 15953429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up.
    Gabrielli O; Clarke LA; Bruni S; Coppa GV
    Pediatrics; 2010 Jan; 125(1):e183-7. PubMed ID: 20026495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthropometric data of 14 patients with mucopolysaccharidosis I: retrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase).
    Tylki-Szymanska A; Rozdzynska A; Jurecka A; Marucha J; Czartoryska B
    Mol Genet Metab; 2010 Jan; 99(1):10-7. PubMed ID: 19783188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I.
    Kakavanos R; Turner CT; Hopwood JJ; Kakkis ED; Brooks DA
    Lancet; 2003 May; 361(9369):1608-13. PubMed ID: 12747881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblings.
    Laraway S; Breen C; Mercer J; Jones S; Wraith JE
    Mol Genet Metab; 2013 Jul; 109(3):315-6. PubMed ID: 23721889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central corneal thickness correlated with glaucoma damage and rate of progression.
    Jonas JB; Stroux A; Velten I; Juenemann A; Martus P; Budde WM
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1269-74. PubMed ID: 15790889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years.
    Sifuentes M; Doroshow R; Hoft R; Mason G; Walot I; Diament M; Okazaki S; Huff K; Cox GF; Swiedler SJ; Kakkis ED
    Mol Genet Metab; 2007 Feb; 90(2):171-80. PubMed ID: 17011223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morpho-functional follow-up of the optic nerve in treated ocular hypertension: disc morphometry and steady-state pattern electroretinogram.
    Salgarello T; Falsini B; Stifano G; Montrone L; Iarossi G; Balestrazzi E; Colotto A
    Curr Eye Res; 2008 Aug; 33(8):709-21. PubMed ID: 18696347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series.
    Horovitz DD; Acosta AX; Giugliani R; Hlavatá A; Hlavatá K; Tchan MC; Lopes Barth A; Cardoso L; Embiruçu de Araújo Leão EK; Esposito AC; Kyosen SO; De Souza CF; Martins AM
    Orphanet J Rare Dis; 2016 Apr; 11(1):51. PubMed ID: 27129473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optic disc progression and rates of visual field change in treated glaucoma.
    De Moraes CG; Liebmann JM; Park SC; Teng CC; Nemiroff J; Tello C; Ritch R
    Acta Ophthalmol; 2013 Mar; 91(2):e86-91. PubMed ID: 23356423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation.
    Valayannopoulos V; de Blic J; Mahlaoui N; Stos B; Jaubert F; Bonnet D; Fischer A; de Lonlay P
    Pediatrics; 2010 Nov; 126(5):e1242-7. PubMed ID: 20974778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial cavitary optic disk anomalies: clinical features of a large family with examples of progressive optic nerve head cupping.
    Honkanen RA; Jampol LM; Fingert JH; Moore MD; Taylor CM; Stone EM; Alward WL
    Am J Ophthalmol; 2007 May; 143(5):788-794. PubMed ID: 17362864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hurler syndrome. Early diagnosis and successful enzyme replacement therapy: a new therapeutic approach. Case report].
    Dupont C; El Hachem C; Harchaoui S; Ribault V; Amiour M; Guillot M; Maire I; Froissart R; Guffon-Fouilhoux N
    Arch Pediatr; 2008 Jan; 15(1):45-9. PubMed ID: 18162380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.